Upcoming Presentations | |
| ISHLT 28th Annual Meeting & Scientific Sessions. April 10, 2008. Boston, MA | Daniel Goldstein MD, Yoshifumi Naka MD, Timothy Icenogle MD, Mark Slaughter MD, et al. "The Epidemiology of Bleeding and Clotting in Pulsatile and Continuous Flow LVAD Patients."(Accepted for Oral Presentation) |
| Platelet Activation in Patients Supported by Continuous Flow Left Ventricular Assist Devices. ISHLT 28th Annual Meeting & Scientific Sessions. | Mark S Slaughter, MD, Michael A Sobieski, CCP, Joel D Graham, et al. "Cardiac Surgery Research and Mechanical Assist Device Program . . . " (Accepted for Oral Presentation) |
| ISHLT 28th Annual Meeting & Scientific Sessions. | Nutter AL, Slaughter MS, Silver MA. "A Decline in the VE/VCO2 Slope from Anaerobic Threshold to Peak Exercise Predicts Short Term Need for LVAD or Heart Transplant."(Accepted for Oral Presentation) |
| more | |
Tel. (630) 789-2296
Myocardial Assist Systems and Technology, LLC
314 Harris Avenue
Clarendon Hills, IL 60514
Expanding & Improving Cardiac Assist Devices
Heart failure—or congestive heart failure—affects the lives of more than 5 million Americans, with more than 550,000 new cases diagnosed each year. Along with heart disease, heart failure is the leading causes of death in both men and women. As the U.S. population ages over the next five years, between 15 to 20 million Americans are expected to be diagnosed with heart failure—far surpassing breast, prostate, and colon cancers in annual diagnosis and mortality.
However—with continued research and development of state-of-the-art myocardial assist devices—there is hope that more and more heart patients can live longer, better lives. Ventricular assist devices (VADs) are essential bridges to transplant for patients with end-stage congestive heart failure. More recently, VADs have also become long-term solutions for heart patients who have no hope for a transplant.
.jpg)
Longer Higher-Quality-of-Living
Myocardial Assist Systems and Technology, LLC (MAST) is committed to the effort of continually developing and improving the high-tech assist devices that cardiac surgeons so desparately need in their fight to save lives.
Led by Dr. Mark Slaughter, a nationally-recognized Chicago cardiothoracic surgeon, experienced researcher, and the current Director of Heart Transplantation and Mechanical Assist Device Program at Advocate Christ Medical Center in Oak Lawn, Illinois, MAST specializes in device technology related to heart surgery, cardiac assist, LVADs, and other cardiac / thorasic assist devices, with services encompassing:
Copyright © 2008. Myocardial Assist Systems and Technology, LLC. Site designed by Caroline Andrew & Associates, LLC
Home | Disclaimer | Privacy Policy | Contact Us